Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rué P[au]:

Cell dynamics and gene expression control in tissue homeostasis and development. Rué P et al. Mol Syst Biol. (2015)

Modeling gene expression in time and space. Rué P et al. Annu Rev Biophys. (2013)

Nac1 Coordinates a Sub-network of Pluripotency Factors to Regulate Embryonic Stem Cell Differentiation. Malleshaiah M et al. Cell Rep. (2016)

Search results

Items: 45

1.

Nac1 Coordinates a Sub-network of Pluripotency Factors to Regulate Embryonic Stem Cell Differentiation.

Malleshaiah M, Padi M, Rué P, Quackenbush J, Martinez-Arias A, Gunawardena J.

Cell Rep. 2016 Feb 9;14(5):1181-1194. doi: 10.1016/j.celrep.2015.12.101. Epub 2016 Jan 28.

2.

FGF/MAPK signaling sets the switching threshold of a bistable circuit controlling cell fate decisions in embryonic stem cells.

Schröter C, Rué P, Mackenzie JP, Martinez Arias A.

Development. 2015 Dec 15;142(24):4205-16. doi: 10.1242/dev.127530. Epub 2015 Oct 28.

3.

A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.

Al-Khattawi A, Koner J, Rue P, Kirby D, Perrie Y, Rajabi-Siahboomi A, Mohammed AR.

Eur J Pharm Biopharm. 2015 Aug;94:1-10. doi: 10.1016/j.ejpb.2015.04.011. Epub 2015 May 7.

4.

Cell cycle-dependent differentiation dynamics balances growth and endocrine differentiation in the pancreas.

Kim YH, Larsen HL, Rué P, Lemaire LA, Ferrer J, Grapin-Botton A.

PLoS Biol. 2015 Mar 18;13(3):e1002111. doi: 10.1371/journal.pbio.1002111. eCollection 2015 Mar.

5.

Cell dynamics and gene expression control in tissue homeostasis and development.

Rué P, Martinez Arias A.

Mol Syst Biol. 2015 Feb 25;11(1):792. doi: 10.15252/msb.20145549. Review.

6.

Wnt/β-catenin and FGF signalling direct the specification and maintenance of a neuromesodermal axial progenitor in ensembles of mouse embryonic stem cells.

Turner DA, Hayward PC, Baillie-Johnson P, Rué P, Broome R, Faunes F, Martinez Arias A.

Development. 2014 Nov;141(22):4243-53. doi: 10.1242/dev.112979.

7.

Brachyury cooperates with Wnt/β-catenin signalling to elicit primitive-streak-like behaviour in differentiating mouse embryonic stem cells.

Turner DA, Rué P, Mackenzie JP, Davies E, Martinez Arias A.

BMC Biol. 2014 Aug 13;12:63. doi: 10.1186/s12915-014-0063-7.

8.

An interplay between extracellular signalling and the dynamics of the exit from pluripotency drives cell fate decisions in mouse ES cells.

Turner DA, Trott J, Hayward P, Rué P, Martinez Arias A.

Biol Open. 2014 Jun 20;3(7):614-26. doi: 10.1242/bio.20148409.

9.

Systematic screening of compressed ODT excipients: cellulosic versus non-cellulosic.

Al-Khattawi A, Iyire A, Dennison T, Dahmash E, Bailey CJ, Smith J, Rue P, Mohammed AR.

Curr Drug Deliv. 2014;11(4):486-500.

PMID:
24655059
10.

A competitive protein interaction network buffers Oct4-mediated differentiation to promote pluripotency in embryonic stem cells.

Muñoz Descalzo S, Rué P, Faunes F, Hayward P, Jakt LM, Balayo T, Garcia-Ojalvo J, Martinez Arias A.

Mol Syst Biol. 2013 Oct 8;9:694. doi: 10.1038/msb.2013.49.

11.

Modeling gene expression in time and space.

Rué P, Garcia-Ojalvo J.

Annu Rev Biophys. 2013;42:605-27. doi: 10.1146/annurev-biophys-083012-130335. Review.

PMID:
23527779
12.

Localized cell death focuses mechanical forces during 3D patterning in a biofilm.

Asally M, Kittisopikul M, Rué P, Du Y, Hu Z, Çağatay T, Robinson AB, Lu H, Garcia-Ojalvo J, Süel GM.

Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18891-6. doi: 10.1073/pnas.1212429109. Epub 2012 Sep 24.

13.

Correlations between the levels of Oct4 and Nanog as a signature for naïve pluripotency in mouse embryonic stem cells.

Muñoz Descalzo S, Rué P, Garcia-Ojalvo J, Martinez Arias A.

Stem Cells. 2012 Dec;30(12):2683-91. doi: 10.1002/stem.1230.

14.

Integration of cellular signals in chattering environments.

Rué P, Domedel-Puig N, Garcia-Ojalvo J, Pons AJ.

Prog Biophys Mol Biol. 2012 Sep;110(1):106-12. doi: 10.1016/j.pbiomolbio.2012.05.003. Epub 2012 May 11.

PMID:
22584015
15.

Information routing driven by background chatter in a signaling network.

Domedel-Puig N, Rué P, Pons AJ, García-Ojalvo J.

PLoS Comput Biol. 2011 Dec;7(12):e1002297. doi: 10.1371/journal.pcbi.1002297. Epub 2011 Dec 8.

16.

Optimizing periodicity and polymodality in noise-induced genetic oscillators.

Rué P, Süel GM, Garcia-Ojalvo J.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Jun;83(6 Pt 1):061904. Epub 2011 Jun 6.

PMID:
21797400
17.

Gene circuit designs for noisy excitable dynamics.

Rué P, Garcia-Ojalvo J.

Math Biosci. 2011 May;231(1):90-7. doi: 10.1016/j.mbs.2011.02.013. Epub 2011 Mar 22.

PMID:
21419138
18.

Relaxation dynamics and frequency response of a noisy cell signaling network.

Rué P, Pons AJ, Domedel-Puig N, García-Ojalvo J.

Chaos. 2010 Dec;20(4):045110. doi: 10.1063/1.3524908.

PMID:
21198122
19.

Simulation methods with extended stability for stiff biochemical Kinetics.

Rué P, Villà-Freixa J, Burrage K.

BMC Syst Biol. 2010 Aug 11;4:110. doi: 10.1186/1752-0509-4-110.

20.

The histone variant macroH2A is an epigenetic regulator of key developmental genes.

Buschbeck M, Uribesalgo I, Wibowo I, Rué P, Martin D, Gutierrez A, Morey L, Guigó R, López-Schier H, Di Croce L.

Nat Struct Mol Biol. 2009 Oct;16(10):1074-9. doi: 10.1038/nsmb.1665. Epub 2009 Sep 6.

PMID:
19734898
21.

Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component.

Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS.

Diabetes. 2002 Jun;51(6):1851-8.

22.

Volmax: simulated gastrointestinal pH and agitation studies.

Rue PJ, Waterhouse J, Cocchetto DM.

DICP. 1991 Apr;25(4):438. No abstract available.

PMID:
1926921
23.

Reevaluation of urine C-peptide as measure of insulin secretion.

Tillil H, Shapiro ET, Given BD, Rue P, Rubenstein AH, Galloway JA, Polonsky KS.

Diabetes. 1988 Sep;37(9):1195-201.

PMID:
3044885
24.

Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia.

Cohen RM, Given BD, Licinio-Paixao J, Provow SA, Rue PA, Frank BH, Root MA, Polonsky KS, Tager HS, Rubenstein AH.

Metabolism. 1986 Dec;35(12):1137-46.

PMID:
3023795
25.

Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.

Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B.

J Clin Invest. 1986 Jan;77(1):98-105.

26.

A radioimmunoassay for circulating human proinsulin.

Cohen RM, Nakabayashi T, Blix PM, Rue PA, Shoelson SE, Root MA, Frank BH, Revers RR, Rubenstein AH.

Diabetes. 1985 Jan;34(1):84-91.

PMID:
3880551
27.

Alterations in hepatic protein kinase activity induced by triiodothyronine.

DeGroot LJ, Rue PA, Nakamura H.

J Endocrinol Invest. 1984 Oct;7(5):429-39.

PMID:
6096434
28.

Pathophysiologic control of nuclear triiodothyronine receptor capacity.

DeGroot LJ, Rue PA.

Acta Endocrinol (Copenh). 1983 Sep;104(1):57-63.

PMID:
6312720
30.

Effect of triiodothyronine on deoxyribonucleic acid-dependent ribonucleic acid polymerase function in rat liver nuclei.

DeGroot LJ, Rue PA.

Endocrinology. 1980 Dec;107(6):1989-97. No abstract available.

PMID:
7428702
31.

Uptake of T3 receptor complex by liver cell nuclei in vitro.

DeGroot LJ, Rue PA.

Acta Endocrinol (Copenh). 1980 Feb;93(2):201-7. No abstract available.

PMID:
6246696
32.

The effect of granule structure on the mechanical properties of tablets [proceedings].

Rue P, Seager H, Burt I, Ryder J, Murray S, Beal N.

J Pharm Pharmacol. 1979 Dec;31 Suppl:73P. No abstract available.

PMID:
42751
33.

Roentgenographic contrast agents inhibit triiodothyronine binding to nuclear receptors in vitro.

DeGroot LJ, Rue PA.

J Clin Endocrinol Metab. 1979 Oct;49(4):538-42.

PMID:
225345
34.

T3 receptor occupancy and metabolic responses.

DeGroot LJ, Rue PA.

J Endocrinol Invest. 1979 Apr-Jun;2(2):183-9. No abstract available.

PMID:
226578
35.

Interbatch variation in compression properties of Elcema G250 [proceedings].

Rees JE, Rue PJ.

J Pharm Pharmacol. 1978 Dec;30 Suppl:25P. No abstract available.

PMID:
32279
36.

Relationship between granule structure, process of manufacture and tableting properties [proceedings].

Seager H, Burt I, Ryder J, Rue P, Murray S, Beal N.

J Pharm Pharmacol. 1978 Dec;30 Suppl:23P. No abstract available.

PMID:
32277
37.

Limitations of the Heckel relation for predicting powder compaction mechanisms.

Rue PJ, Rees JE.

J Pharm Pharmacol. 1978 Oct;30(10):642-3. No abstract available.

PMID:
30819
38.

Time-dependent deformation of some direct compression excipients.

Rees JE, Rue PJ.

J Pharm Pharmacol. 1978 Oct;30(10):601-7.

PMID:
30812
39.

Nuclear receptors for thyroid hormone.

DeGroot LJ, Refetoff S, Bernal J, Rue PA, Coleoni AH.

J Endocrinol Invest. 1978 Jan;1(1):79-88. No abstract available.

PMID:
226575
40.

Triiodothyronine stimulates nuclear RNA synthesis.

DeGroot LJ, Rue P, Robertson M, Bernal J, Scherberg N.

Endocrinology. 1977 Dec;101(6):1690-700. No abstract available.

PMID:
590185
41.

Work-of-failure measurements on formulated tablets [proceedings].

Rees JE, Rue PJ, Richardson SC.

J Pharm Pharmacol. 1977 Dec;29 Suppl:38P. No abstract available.

PMID:
22668
42.

Elastic and visco-elastic properties of compressed tablets [proceedings].

Rees JE, Rue PJ.

J Pharm Pharmacol. 1977 Dec;29 Suppl:37P. No abstract available.

PMID:
22667
43.

Reduced nuclear triiodothyronine receptors in starvation-induced hypothyroidism.

DeGroot LJ, Coleoni AH, Rue PA, Seo H, Martino E, Refetoff S.

Biochem Biophys Res Commun. 1977 Nov 7;79(1):173-8. No abstract available.

PMID:
200237
44.

Triiodothyronine receptors during maturation.

DeGroot LJ, Robertson M, Rue PA.

Endocrinology. 1977 Jun;100(6):1511-5.

PMID:
192539
45.

Binding of nuclear triiodothyronine (T3) binding protein-T3 complex to chromatin.

DeGroot LJ, Hill L, Rue P.

Endocrinology. 1976 Dec;99(6):1605-11.

PMID:
11991

Supplemental Content

Support Center